期刊論文/Journal Paper

1 何俊德(Chun-Te Ho)、江鈞綺(YC-Liu)、陳朝榮(Chao-Jung Chen)、鄭維中(Cheng, Wei-Chung)、江鈞綺(CC-Lin)、江鈞綺(WR-Wang)、江鈞綺(XH-Huang)、江鈞綺(Chun-Chi Chiang)、賴泓茵(Hung Yin,Lai)、蔡宜佑(Yi-Yu Tsai)、(LY-Chou)、嚴玉婷(Yu-Ting Yen)、王鍵元(Chien-Yuan Wang)、許弘昌(Horng-Chaung Hsu)、洪士杰(Shih-Chieh Hung)*,Precision Stem Cell Regeneration Enabled by a Collagen-Targeting, Fate-Directing Bi-Functional Peptide,BIOMATERIALS,2026 May,328():123807,SCI
2 (Cian-Ru Yang)、廖珮吟(Liao, Pei-Yin)、林文仁(LIN WEN-JEN)、沈培鈞、(Ke Wang)、蘇鈺婷(SU, Yu-Ting)、鄭維中(Cheng, Wei-Chung)、張維君(Wei-Chun Chang)、李仁智(Jen-Chih Lee)、彭成元(Peng, Cheng-Yuan)、賴學洲(Hsueh-Chou Lai)、馬文隆(Wen-Lung Ma)*,Very Low-density Lipoprotein-triacylglyceride Promotes Hepatitis B Virus Reactivation,Journal of Physiological Investigation,2026 Feb,69(1):,SCI
3 Mahdieh Safaei(MAHDIEH SAFAEI)、李易撰(Li, Yi-Chuan)、(Chung-Yu Chen)、(Ping-Hua Hsieh)、Srimathi Venkataraman(SRIMATHI VENKATARAMAN)、黃偉謙(Huang, Wei-Chien)、鄭維中(Cheng, Wei-Chung)、山口浩史(Yamaguchi Hirohito)、陳郁夫(Chen, Yu-Fu)、何元順(Ho, Yuan-Soon)、張為超(Wei-Chao Chang)、林志偉(Chih-Wei Lin)*、洪明奇(Mien-Chie Hung)*,Targeting Ephrin receptor A10 with antibody-drug conjugates for breast cancer,CANCER LETTERS,2026 Feb,639():218225,SCI
4 (JH-Lin)、(TW-Hsu)、鄭維中(Cheng, Wei-Chung)、(CC-Liu)、(Anna FY-Li)、洪明奇(Mien-Chie Hung)、(HS-Hsu)*、洪士杰(Shih-Chieh Hung)*,YAP/TEAD-Activated TAG Synthesis and Peroxidation in Lipid Droplets Confer ROS Resistance in Cancer Stem Cells.,Redox Biology,2026 Feb,89():10398,SCI
5 何俊德(Chun-Te Ho)、(LH-Li)、鄭維中(Cheng, Wei-Chung)、吳恒祥(Wu, Heng-Hsiung)、陳雅惠(Ya-Huey Chen)、洪士杰(Shih-Chieh Hung)*,TRIM37–PARP1–TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulation,Nature Communications,2025 Dec,():,SCI
6 林文仁(Wen-Jen Lin)、王又德(Yu-De Wang)、(Chia-Hsin Liu)、劉修誠(LIU, HSIU-CHENG)、沈培鈞、陳亞萱(Chen Ya Hsuan)、梁瑋庭(Liang, Wei-Ting)、(You-Zhe Lin)、王紹椿(Shao-Chun Wang)、賴宥良(Yo-Liang Lai)、鄭維中(Cheng, Wei-Chung)*,ImmiR: A database of microRNAs associated with immune checkpoints and infiltrates,Computational and Structural Biotechnology Journal,2025 Nov,27():5281-5288,SCI
7 許榮茂(Hsu,Jung-Mao)*、(Chunxiao Liu)、(Weiya Xia)、陳崇裕(CHUNG-YU CHEN)、鄭維中(Cheng, Wei-Chung)、(Junwei Hou)、洪明奇(Mien-Chie Hung)*,MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists,SCIENCE,2025 Oct,390(6769):,SCI
8 賴宥良(Yo-Liang Lai)、(Chun-Chieh Wang)、許凱文(Hsu, Kai-Wen)、(Ching-Fang Yu)、(Yung-Lun Lin)、沈培鈞、蔡孟欣、(Fang-Hsin Chen)*、鄭維中(Cheng, Wei-Chung)*,Integrative multi-omics and preclinical analyses identify miR-4776-5p as a prognostic radiosensitizer for patients undergoing radiotherapy for head-and-neck cancer,Discover Oncology,2025 Oct,16(1):1979,SCI
9 (Tzu-Chieh Sun)、(Ching-Fang Yu)、(Sheng-Yan Wu)、鄭維中(Cheng, Wei-Chung)、(Chi-Shiun Chiang)、(Fang-Hsin Chen)*,Microglia Limit Brain Tumor Development by Restricting Tumor Cell Proliferation and Inducing T-cell Immunity,Molecular Oncology,2025 Sep,19(9):2670-2685,SCI
10 廖珮吟(Liao, Pei-Yin)、林文仁(LIN WEN-JEN)、(Pei-Chun Shen)、(Cian?Ru Yang)、(Ying?Chun Yu)、葉俊杰(Yeh, Chun-Chieh)、鄭隆賓(Long-Bin Jeng)、賴學洲(Hsueh-Chou Lai)、鄭維中(Cheng, Wei-Chung)*、馬文隆(Wen-Lung Ma)*,Ether-lipids accumulation promotes hepatocellular carcinoma progression linked to PPARα deficiency,JOURNAL OF BIOMEDICAL SCIENCE,2025 Sep,32():89,SCI
11 林文仁(LIN WEN-JEN)、劉佳鑫、(Ming-Siang Huang)、沈培鈞、劉修誠(LIU, HSIU-CHENG)、蔡孟欣(Meng-Hsin Tsai)、賴宥良(Yo-Liang Lai)、王又德(Yu-De Wang)、洪明奇(Mien-Chie Hung)、(Nai-Wen Chang)*、鄭維中(Cheng, Wei-Chung)*,LipidFun: A Database of Lipid Functions,BIOINFORMATICS,2025 Apr,41(4):1-10,SCI
12 林佑哲(You-Zhe Lin)、劉佳鑫、鄔宛蓉、廖庭儀(Liao, Ting-Yi)、李權峻(Chuan-Chun Lee)、李浤維(Li, Houng-Wei)、鍾鳳祈(CHUNG, FENG-CHI)、沈宜君、卓冠宇(Guan-Yu Zhuo)、劉良智(Liang-Chih Liu)、鄭維中(Cheng, Wei-Chung)、王紹椿(Shao-Chun Wang)*,Memory-promoting function of miR-379-5p attenuates CD8+ T cell exhaustion by targeting immune checkpoints,Journal for ImmunoTherapy of Cancer,2025 Apr,13(4):1-18,SCI
13 劉佳鑫、沈培鈞、蔡孟欣、劉修誠(LIU, HSIU-CHENG)、林文仁(LIN WEN-JEN)、賴宥良(Yo-Liang Lai)、王又德(Yu-De Wang)、洪明奇(Mien-Chie Hung)、鄭維中(Cheng, Wei-Chung)*,LipidSigR: A R-Based Solution for Integrated Lipidomics Data Analysis and Visualization,Bioinformatics Advances,2025 Mar,5(1):,Other
14 蘇鈺婷(SU, Yu-Ting)、張維君(Wei-Chun Chang)、陳璐敏(Lu-Min Chen)、余盈君、林文仁(LIN WEN-JEN)、林政佑(LIN, JHENG-YOU)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、洪耀欽(Hung, Yao-Ching)*、馬文隆(Wen-Lung Ma)*,Ether-Linked Glycerophospholipids Are Potential Chemo-Desensitisers and Are Associated With Overall Survival in Carcinoma Patients,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2024 Dec,28():e70277,SCI
15 (Pin-Rong Chen)、(Chia-Yang Li)、(Taha Yazal)、(I-Chen Chen)、(Po-Len Liu)、(Yi-Ting Chen)、(Ching-Chih Liu)、(Jung Lo)、(Tzu-Chieh Lin)、(Ching-Tang Chang)、(Hsin-En Wu)、(Yuan-Ru Chen)、鄭維中(Cheng, Wei-Chung)、(Chien-Chih Chiu)、(Chi-Shuo Chen)、(Shu-Chi Wang)*,Protective effects of nordalbergin against LPS-induced endotoxemia through inhibiting MAPK/NF-κB signaling pathway, NLRP3 inflammasome activation, and ROS production,INFLAMMATION RESEARCH,2024 Oct,73(10):1657-1670,SCI
16 劉佳鑫、沈培鈞、林文仁(LIN WEN-JEN)、劉修誠(LIU, HSIU-CHENG)、蔡孟欣(TSAI MENG-HSIN)、黃姿雅(Huang, Tzu-Ya)、陳怡潔(CHEN I-CHIEH)、賴宥良(Yo-Liang Lai)、王又德(Yu-De Wang)、洪明奇(Mien-Chie Hung)、鄭維中(Cheng, Wei-Chung)*,LipidSig 2.0: integrating lipid characteristic insights into advanced lipidomics data analysis,NUCLEIC ACIDS RESEARCH,2024 May,52(W1):W390-W397,SCI
17 劉璟霈(Liu, Jing-Pei)、(Kuan-Yin Shen)、鄭維中(Cheng, Wei-Chung)、張為超(Wei-Chao Chang)、(Chih-Ying Hsieh)、(Chia-Chien Lo)、(Ting-Ting Kuo)、林精湛(Ching-Chan Lin)、(Shih-Jen Liu)、黃文欽(Huang,Wen-Chin)*、佘玉萍(Yuh-Pyng Sher)*,ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression,American Journal of Cancer Research,2024 Apr,14(4):1850-1865,SCI
18 (Michael Anekson Widjaya)、李信達(Shin-Da Lee)、鄭維中(Cheng, Wei-Chung)、(Bor-Tsang Wu)*,Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review,JOURNAL OF ALZHEIMERS DISEASE,2024 Apr,98(4):1219-1234,SCI
19 劉佳鑫、賴宥良(Yo-Liang Lai)、沈培鈞、劉修誠(LIU, HSIU-CHENG)、蔡孟欣(TSAI MENG-HSIN)、王又德(Yu-De Wang)、林文仁(LIN WEN-JEN)、(Fang-Hsin Chen)、(Chia-Yang Li)、(Shu-Chi Wang)、洪明奇(Mien-Chie Hung)、鄭維中(Cheng, Wei-Chung)*,DriverDBv4: a multi-omics integration database for cancer driver gene research,NUCLEIC ACIDS RESEARCH,2024 Jan,52(D1):D1246-D1252,SCI
20 黃裕鍇(Huang, Yu-Kai)、鄭維中(Cheng, Wei-Chung)、郭婷婷、楊顓丞(Juan-Cheng Yang)、吳永昌(Yang-Chang Wu)、吳恒祥(Wu, Heng-Hsiung)、羅佳茜(Chia-Chien Lo)、謝知穎(Chih-Ying Hsieh)、黃思澄(Sze-Ching Wong)、陸志豪(Chih-Hao Lu)、(Wan-Ling Wu)、劉士任(Shih-Jen Liu)、李易撰(Li, Yi-Chuan)、林精湛(Ching-Chan Lin)、沈家寧(Chia-Ning Shen)、洪明奇(Mien-Chie Hung)、林肇堂(Jaw-Town Lin)、葉俊杰(Yeh, Chun-Chieh)*、佘玉萍(Yuh-Pyng Sher)*,Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy,Nature Cancer,2024 Jan,5(3):400-419,SCI
21 楊茜如(YANG CIAN-RU)、林文仁(LIN WEN-JEN)、沈培鈞、廖珮吟(Liao, Pei-Yin)、(Yuan-Chang Dai)、洪耀欽(Yao-Ching Hung)、賴學洲(Hsueh-Chou Lai)、Shiraz Mehmood(SHIRAZ MEHMOOD)、鄭維中(Cheng, Wei-Chung)*、馬文隆(Wen-Lung Ma)*,Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis,Biomarker Research,2024 Jan,12(1):1-17,SCI
22 (Yuan-Chin Tsai)、(Shu-Pin Huang)、鄭維中(Cheng, Wei-Chung)、(Yu-Ching Fan)、(Ya-Ching Lin)、(Shin-Yu Tsai)、(Chao-Yuan Huang)、(Chia-Cheng Yu)、(Victor C Lin)、(Jiun-Hung Geng)、(Chia-Yang Li)、陸德齡(TE-LING LU)、鮑柏穎(Bao, Bo-Ying)*,Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation,American Journal of Cancer Research,2024 Jan,14(1):169-181,SCI
23 彭姵華(Pei-Hua Peng)、陳紀琳(Ji-Lin Chen)、吳恒祥(Wu, Heng-Hsiung)、楊文豪(Yang,Wen-Hao)、林莉婕(Lin, Li-Jie)、賴玠羽(Lai, Chieh-Yu)、張正守(Jeng-Shou Chang)、許嘉凌(Jia-Ling Syu)、吳函蒼(Han-Tsang Wu)、許斐婷(Hsu, Fei-Ting)*、鄭維中(Cheng, Wei-Chung)*、許凱文(Hsu, Kai-Wen)*,Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis,Cancer Cell International,2023 Nov,23(1):1-13,SCI
24 黃安順(Michael Anekson Widjaya)、劉佳鑫、李信達(Shin-Da Lee)、鄭維中(Cheng, Wei-Chung)*,Transcriptomics Meta-Analysis Reveals Phagosome and Innate Immune System Dysfunction as Potential Mechanisms in the Cortex of Alzheimer's Disease Mouse Strains,JOURNAL OF MOLECULAR NEUROSCIENCE,2023 Oct,73(9-10):773-786,SCI
25 (Ivonne Melano)、鄭維中(Cheng, Wei-Chung)、(Li-Lan Kuo)、(Yuag-Meng Liu)、(Yu Chi Chou)、洪明奇(Mien-Chie Hung)、賴明詔(Michael Lai)、佘玉萍(Yuh-Pyng Sher)*、蘇文琪(Wen-Chi Su)*,A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression,Microbiology Spectrum,2023 Sep,():,SCI
26 (Xuan Hong)、謝閔凔(Min-Tsang Hsieh)、曾子育、林慧怡(Lin, Hui-Yi)、張閎智(Chang, Hong-Chi)、姚絲琁(Yau Sir Theng)、鄭維中(Cheng, Wei-Chung)、(Baozhen Ke)、(Hsiao-Hui Liao)、(Chih-Ying Wu)、劉安安(Liu, An An)、(Meei-Maan Wu)、(Kuo-Yen Huang)、(Pan-Chyr Yang)、郭盛助(Sheng-Chu kuo)、洪明奇(Mien-Chie Hung)*、李培志(Lee, Pei-Chih)*,Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma,JOURNAL OF BIOLOGICAL CHEMISTRY,2023 Jun,299(6):1-16,SCI
27 張敬昆、張光喜(Kuang-Hsi Chang)、鄭維中(Cheng, Wei-Chung)、陳柏谷(PoKu Chen)、蔣恩沛(En-Pei Isabel Chiang)、張詩欣(Shih-Hsin Chang)、(Yi-Chen Li)、陳珠璜(Chu-Huang Chen)、陳得源(Der-Yuan Chen)*,Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis,CLINICAL AND EXPERIMENTAL RHEUMATOLOGY,2023 May,41(5):1120-1128,SCI
28 (Widjaya, Michael Anekson)、鄭宇容(Cheng, Yu-Jung)、(Kuo, Yu-Min)、(Liu, Chia-Hsin)、鄭維中(Cheng, Wei-Chung)*、李信達(Shin-Da Lee)*,Transcriptomic Analyses of Exercise Training in Alzheimer’s Disease Cerebral Cortex,JOURNAL OF ALZHEIMERS DISEASE,2023 May,93(1):349-363,SCI
29 (Hsiang?Chun Lee)*、鄭維中(Cheng, Wei-Chung)、馬文隆(Wen-Lung Ma)、(Yu?Hsun Lin)、(Shyi?Jang Shin)、(Yi?Hsiung Lin),Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome,Scientific Reports,2023 Apr,(2023):13-6575,SCI
30 (Hsin-En Wu)、(Chia-Cheng Su)、(Shu-Chi Wang)、(Po-Len Liu)、鄭維中(Cheng, Wei-Chung)、(Hsin-Chih Yeh)、(Chih-Pin Chuu)、(Jen-Kun Chen)、鮑柏穎(Bao, Bo-Ying)、(Cheng Hsueh Lee)、(Chien-Chih Ke)、(Yuan-Ru Chen)、(Yun-Hsin Yu)、(Shu-Pin Huang)*、(Chia-Yang Li)*,Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway,AMERICAN JOURNAL OF CHINESE MEDICINE,2023 Apr,():,SCI
31 (Chen YR)、(Wang SC)、(Huang SP)、(Su CC)、(Liu PL)、鄭維中(Cheng, Wei-Chung)、(Chuu CP)、(Chen JK)、鮑柏穎(Bao, Bo-Ying)、(Lee CH)、(Ke CC)、(Wu HE)、(Chang HH)、(Yeh HC)*、(Li CY)*,Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways,BIOMEDICINE & PHARMACOTHERAPY,2022 Dec,156():113929,SCI
32 余盈君、(Azaj Ahmad)、賴學洲(Hsueh-Chou Lai)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、張維君(Wei-Chun Chang)、陳璐敏(Lu-Min Chen)、沈延盛*、馬文隆(Wen-Lung Ma)*,Review of the Endocrine Organ–Like Tumor Hypothesis of Cancer Cachexia in Pancreatic Ductal Adenocarcinoma,Frontiers in Oncology,2022 Nov,1057930():,SCI
33 陸自利(Lu, Tzu-Li)、佘玉萍(Yuh-Pyng Sher)、陳惠珍(Chen, Hui-Chen)、鄭維中(Cheng, Wei-Chung)、徐令恆、李珍珍(Chen-Chen Lee)*,Articulatin B chain induced dendritic cells maturation and driven type I T helper cells and cytotoxic T cells activation,LIFE SCIENCES,2022 Aug,302(2022):120635,SCI
34 劉佳鑫、劉淑萱(Shu-Hsuan)、賴宥良(Yo-Liang Lai)、(Yi-Chun Cho)、(Fang-Hsin Chen)、林莉婕(Lin, Li-Jie)、(Pei-Hua Peng)、(Chia-Yang Li)、(Shu-Chi Wang)、(Ji-Lin Chen)、吳恒祥(Wu, Heng-Hsiung)、(Min-Zu Wu)、佘玉萍(Yuh-Pyng Sher)、鄭維中(Cheng, Wei-Chung)*、許凱文(Hsu, Kai-Wen)*,Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma,Computational and Structural Biotechnology Journal,2022 Aug,():,SCI
35 邱建勳(Chiou, Jian-Shium)、鄭奇(Chi-Fung Cheng)、梁文敏(Liang Wen-Miin)、周振興(Chou, Chen-Hsing)、王仲興(Chung-Hsing Wang)、林瑋德(Wei-De Lin)、邱慕霖(Chiu, Mu-Lin)、鄭維中(Cheng, Wei-Chung)、林振文(Lin, Cheng-Wen)、林亭旭(Ting-Hsu Lin)、廖秋菊(Chiu-Chu Liao)、黃少玫(Huang, Shao-Mei)、蔡長海(Chang-Hai Tsai)、林應如(Ying-Ju Lin)*、蔡輔仁(Fuu-Jen Tsai)*,Your height affects your health: Genetic determinants and health-related outcomes in Taiwan,BMC Medicine,2022 Jul,20(250):,SCI
36 (Hsin-Chih Yeh)、(Chia-Cheng Su)、(Yen-Hsuan Wu)、(Cheng Hsueh Lee)、鮑柏穎(Bao, Bo-Ying)、鄭維中(Cheng, Wei-Chung)、(Shu-Chi Wang)、(Po-Len Liu)、(Chien-Chih Chiu)、(Chih-Pin Chuu)、(Chien-Chih Ke)、(Hsin-En Wu)、(Yuan-Ru Chen)、(Wei-Ju Chung)、(Shu-Pin Huang)*、(Chia-Yang Li)*,Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer,European Journal of Pharmacology,2022 May,923():,SCI
37 (Li CY)、(Huang SP)、(Chen YT)、(Wu HE)、鄭維中(Cheng, Wei-Chung)、(Huang CY)、(Yu CC)、(Lin VC)、(Geng JH)、陸德齡(TE-LING LU)、鮑柏穎(Bao, Bo-Ying)*,TNFRSF13B is a potential contributor to prostate cancer,Cancer Cell International,2022 May,22(1):180,SCI
38 賴宥良(Yo-Liang Lai)、劉佳鑫、(Shu-Chi Wang)、(Shu-Pin Huang)、(Yi-Chun Cho)、鮑柏穎(Bao, Bo-Ying)、(Chia-Cheng Su)、(Hsin-Chih Yeh)、(Cheng-Hsueh Lee)、(Pai-Chi Teng)、(Chih-Pin Chuu)、(Deng-Neng Chen)、(Chia-Yang Li)*、鄭維中(Cheng, Wei-Chung)*,Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis,Cancers,2022 Mar,14(6):1565,SCI
39 (Fen-Lan Wu)、朱珮儀、陳冠宇(Guan-Yu Chen)、(Ke Wang)、徐瑋佑、(Azaj Ahmed)、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、吳永昌(Yang-Chang Wu)*、楊顓丞(Juan-Cheng Yang)*,Natural Anthraquinone Compound Emodin as a Novel Inhibitor of Aurora A kinase: A pilot study,Chemical Biology & Drug Design,2022 Jan,99(1):126-135,SCI
40 林佑哲(You-Zhe Lin)、(Shu-Hsuan Liu)、鄔宛蓉、沈宜君(Shen, Yi-Chun)、王元良(Yuan-Liang Wang)、(Chien-Ching Liao)、(Pei-Le Lin)、張菡(Han Chang)、劉良智(Liang-Chih Liu)、鄭維中(Cheng, Wei-Chung)*、王紹椿(Shao-Chun Wang)*,miR-4759 suppresses breast cancer through immune checkpoint blockade,Computational and Structural Biotechnology Journal,2021 Dec,20():241-251,SCI
41 張敬昆、鄭維中(Cheng, Wei-Chung)、馬文隆(Wen-Lung Ma)、陳柏谷(PoKu Chen)、(Chu-Huang Chen)、沈培鈞(Pei-Chun Shen)、(Chia-Ching Chen)、張詩欣(Shih-Hsin Chang)、賴怡樺(LAI YI-HUA)、陳得源(Der-Yuan Chen)*,The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2021 Oct,22(21):11419,SCI
42 (Ciniso Sylvester Shabangu)、(Phumelele Yvonne Siphepho)、(Chia-Yang Li)、鄭維中(Cheng, Wei-Chung)、(Ming-Ying Lu)、(Chung-Feng Huang)、(Ming-Lun Yeh)、(Chia-Yen Dai)、(Jee-Fu Huang)、(Wan-Long Chuang)、(Zu-Yau Lin)、(Ming-Lung Yu)、(Shu-Chi Wang)*,The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression,Biomedicines,2021 Oct,9(10):1446,SCI
43 (Pai-Chi Teng)、(Shu-Pin Huang)、劉佳鑫、(Ting-Yi Lin)、卓奕君、賴宥良(Yo-Liang Lai)、(Shu-Chi Wang)、(sin-Chih Yeh)、(Chih-Pin Chuu)、(Deng-Neng Chen)、鄭維中(Cheng, Wei-Chung)*、(Chia-Yang Li)*,Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2021 Oct,22(221):11771,SCI
44 劉淑萱(Liu, Shu-Hsuan)、許凱文(Hsu, Kai-Wen)、賴宥良(Yo-Liang Lai)、(Lin YF)、(Chen FH)、(Peng PH)、林莉婕(Lin, Li-Jie)、吳恒祥(Wu, Heng-Hsiung)、(Chia-Yang Li)、Wang SC、(Wu MZ)、佘玉萍(Yuh-Pyng Sher)*、鄭維中(Cheng, Wei-Chung)*,Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma,Molecular Therapy-Nucleic Acids,2021 Sep,25():1-10,SCI
45 林昱森(Yu-Sen Lin)、郭婷婷、羅佳茜(CHIA-CHIEN, LO)、鄭維中(Cheng, Wei-Chung)、張為超(Wei-Chao Chang)、曾冠欽(Guan-Chin Tseng)、白詩婷(Bai, Shih-Ting)、黃裕鍇、謝知穎、許瀚水(Han-Shui Hsu)、江逸凡(Yi-Fan Jiang)、林振源(Lin, Chen-Yuan)、(Liang-Chuan Lai)、李興國(Li, Xing-Guo)、佘玉萍(Yuh-Pyng Sher)*,ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma,International Journal of Biological Sciences,2021 Sep,17(14):3898-3910,SCI
46 (Po-Yen Lee)、(Ching-Chih Liu)、(Shu-Chi Wang)、(Kai-Yin Chen)、(Tzu-Chieh Lin)、(Po-Len Liu)、(Chien-Chih Chiu)、(I-Chen Chen)、(Yu-Hung Lai)、鄭維中(Cheng, Wei-Chung)、(Wei-Ju Chung)、(Hsin-Chih Yeh)、(Chi-Han Huang)、(Chia-Cheng Su)、(Shu-Pin Huang)、(Chia-Yang Li)*,Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages,Toxins,2021 Sep,13(9):593,SCI
47 (Po-Yen Lee)、(Yu-Hung Lai)、(Po-Len Liu)、(Ching-Chih Liu)、(Chia-Cheng Su)、(Fang-Yen Chiu)、鄭維中(Cheng, Wei-Chung)、(Shiuh-Liang Hsu)、(Kai-Chun Cheng)、(Li-Yi Chiu)、(Tzu-En Kao)、(Chia-Ching Lin)、(Yo-Chen Chang)、(Shu-Chi Wang)*、(Chia-Yang Li)*,Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells,Scientific Reports,2021 Sep,11(1):18514,SCI
48 黃介良(Chieh-Liang Huang)、江耀璋、張維君(Wei-Chun Chang)、蘇鈺婷(Su, Yu-Ting)、楊顓丞(Juan-Cheng Yang)、鄭維中(Cheng, Wei-Chung)、藍先元(Hsien-Yuan Lane)、何英剛、馬文隆(Wen-Lung Ma)*,Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment,Frontiers in Endocrinology,2021 Aug,12():,SCI
49 王元良(Yuan-Liang Wang)、李權峻(Chuan-Chun Lee)、沈宜君(Shen, Yi-Chun)、(Pei-Le Lin)、鄔宛蓉、林佑哲(You-Zhe Lin)、鄭維中(Cheng, Wei-Chung)、張菡(Han Chang)、(Yu Hung)、(Yi-Chun Cho)、劉良智(Liang-Chih Liu)、(Wei-Ya Xia)、紀金輝(Jin-Huei Ji)、梁基安(Ji-An Liang)、(Shu-Fen Chiang)、(Chang-Gong Liu)、(Jun Yao)、洪明奇(Mien-Chie Hung)*、王紹椿(Shao-Chun Wang)*,Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA,Cell Reports,2021 Aug,36(8):109537,SCI
50 林文仁(Lin, Wun-Ren)、沈培鈞、劉修誠、卓奕君、徐敏恭、林依真(Lin, I-Chen)、(Chen FH)、楊顓丞(Juan-Cheng Yang)、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)*,LipidSig: a web-based tool for lipidomic data analysis,NUCLEIC ACIDS RESEARCH,2021 Jul,49(w1):W336-W345,SCI
51 (Jeffrey Yung-chuanChao)、(Hsin-Chuan Chang)、(Jeng-Kai Jiang)、(Chih-Yung Yang)、(Fang-Hsin Chen)、賴宥良(Yo-Liang Lai)、林文仁(Lin, Wun-Ren)、(Chia-Yang Li)、(Shu-Chi Wang)、(Muh-Hwa Yang)、(Yu-Feng Lin)*、鄭維中(Cheng, Wei-Chung)*,Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer,Computational and Structural Biotechnology Journal,2021 Jul,19():3922-3929,SCI
52 何宥豪(He, Yu-Hao)、葉名焮、陳筱凡(Chen Hsiao-Fan)、(Wang T.-S)、(Wong R.-H)、魏雅鈴(Ya-Ling Wei)、Huynh Kieu Thanh(Huynh Kieu Thanh)、胡玳瑋、鄭方茹(Cheng, Fang-Ju)、陳貞妤、胡書瑋(Hu, Shu-Wei)、(Huang C.-C.)、陳曄(Chen,Yeh)、游家鑫(Jiaxin Yu)、鄭維中(Cheng, Wei-Chung)、(Shen P.-C)、劉良智(Liang-Chih Liu)、黃至豪(Huang ChihHao)、(Chang Y.-J)、黃偉謙(Huang, Wei-Chien)*,ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions,Molecular Therapy-Nucleic Acids,2021 Jul,25():536-553,SCI
53 (Chi-Han Huan)、(Shu-Chi Wang)、(I-Chen Chen)、(Yi-Ting Chen)、(Po-Len Liu)、(Shih-Hua Fan)、(Shu-Pin Huang)、(Hsin-Chih Ye)、(Ching-Chih L)、(Po-Yen Lee)、(Tzu-Chieh Li)、鄭維中(Cheng, Wei-Chung)、(Chia-Cheng Su)、(Hsin-En Wu)、(Yuan-Ru Chen)、(Chia-Yang Li)*,Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation,Pharmaceuticals,2021 Jun,14(6):588,SCI
54 (Shu-Chi Wang)、(Chia-Yang Li)、(Wen-Tsan Chang)、鄭維中(Cheng, Wei-Chung)、(Chia-Hung Yen)、(Wen-Yu Tu)、(Zu-Yau Lin)、(Ching-Chih Lin)、(Ming-Lun Yeh)、(Chung-Feng Huang)、(Jee-Fu Huang)、(Chia-Yen Dai)、(Wan-Long Chuang)、(Yao-Li Chen)*、(Ming-Lung Yu)*,Exosome-derived differentiation antagonizing non-protein coding RNA with risk of HCV-related hepatocellular carcinoma recurrence,LIVER INTERNATIONAL,2021 May,41(5):956-968,SCI
55 (Chia-Cheng Su)、(Shu-Chi Wang)、(I-Chen Chen)、(Fang-Yen Chiu)、(Po-Len Liu)、(Chi-Han Huang)、(Kuan-Hua Huang)、(Shih-Hua Fang)、鄭維中(Cheng, Wei-Chung)、(Shu-Pin Huang)、(Hsin-Chih Yeh)、(Ching-Chih Liu)、(Po-Yen Lee)、(Ming-Yii Huang)、(Chia-Yang Li)*,Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages,Frontiers in Pharmacology,2021 May,12():,SCI
56 (Lai TS)、鄭維中(Cheng, Wei-Chung)、(Yang CY)、(Chen YQ)、(Su SH)、(Yeh TY)、(Lan HY)、(Lee CC)、(Lin HH)、(Lin CC)、(Lu RH)、(Chiou ET)、(Jing JK)*、(Hwang WL)*,The microRNA-210-Stathmin1 Axis Decreases Cell Stiffness to Facilitate the Invasiveness of Colorectal Cancer Stem Cells,Cancers,2021 Apr,13(8):1833,SCI
57 林晏安(Lin, Yen-An)、朱珮儀、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、(Shu-Ting Chan)、楊顓丞(Juan-Cheng Yang)*、吳永昌(Yang-Chang Wu)*,Enzyme-Digested Peptides Derived from Lates calcarifer Enhance Wound Healing after Surgical Incision in a Murine Model,Marine Drugs,2021 Mar,19(3):154,SCI
58 鄭維中(Cheng, Wei-Chung)、(Chun-Yu Chang)、羅佳茜(CHIA-CHIEN, LO)、(Chih-Ying Hsieh)、郭婷婷、曾冠欽、黃思澄、姜淑芬、黃智洋(Huang, Kevin Chih-Yang)、(Liang-Chuan Lai)、(Tzu-Pin Lu)、趙坤山(Kun-San Chao)*、佘玉萍(Yuh-Pyng Sher)*,Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma,Theranostics,2021 Jan,11(8):3661-3675,SCI
59 (Yumei Qi)、賴宥良(Yo-Liang Lai)、沈培鈞、(Fang-Hsin Chen)、林莉婕(Lin, Li-Jie)、吳恒祥(Wu, Heng-Hsiung)、(Pei-Hua Peng)、許凱文(Hsu, Kai-Wen)*、鄭維中(Cheng, Wei-Chung)*,Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach,Scientific Reports,2020 Dec,10(1):22270,SCI
60 蔡隆宏(Lung-Hung Tsai)、許凱文(Hsu, Kai-Wen)、江正明(Chiang, Cheng-Ming)、楊琇茹(Yang, Hsiu-Ju)、呂郁蕙(Yu-Huei Liu)、楊順發(Yang, Shun-Fa)、彭佩華(Peng, Pei-Hua)、鄭維中(Cheng, Wei-Chung)、吳恒祥(Wu, Heng-Hsiung)*,Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer,Scientific Reports,2020 Oct,10(1):17817,SCI
61 林精湛(Ching-Chan Lin)、黃裕鍇、(Chia-Fong Cho)、林昱森(Yu-Sen Lin)、羅佳茜(CHIA-CHIEN, LO)、郭婷婷、(曾冠欽)、鄭維中(Cheng, Wei-Chung)、張為超(Wei-Chao Chang)、蕭自宏、賴亮全、施金元、呂郁蕙(Yu-Huei Liu)、趙坤山(Kun-San Chao)、(Jennifer L. Hsu)、李培志(Lee, Pei-Chih)、(Xian Sun)、洪明奇(Mien-Chie Hung)、佘玉萍(Yuh-Pyng Sher)*,Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.,Theranostics,2020 Aug,10(24):10925-10939,SCI
62 Lumin Chen、馬文隆(Wen-Lung Ma)、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、王筱晴、蘇鈺婷、(Azaj Ahmed)、洪耀欽(Yao-Ching Hung)、張維君(Wei-Chun Chang)*,Targeting Lipid Droplet Lysophosphatidylcholine for Cisplatin Chemotherapy,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2020 Jul,24(13):7187-7200,SCI
63 (Ke CC)、(Chen LC)、(Yu CC)、鄭維中(Cheng, Wei-Chung)、(Huang CY)、(Lin VC)、陸德齡、(Huang SP)*、鮑柏穎*,Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese Men,Cancers,2020 May,12(5):1346,SCI
64 張維君(Wei-Chun Chang)、王筱晴、鄭維中(Cheng, Wei-Chung)、楊顓丞(Juan-Cheng Yang)、鍾瑋敏(Wei-Min Chung)、(Yen-Pin Ho)、(Lumin Chen)、洪耀欽(Yao-Ching Hung)、馬文隆(Wen-Lung Ma)*,LDLR-Mediated Lipidome-Transcriptome Reprogramming in Cisplatin Insensitivity,ENDOCRINE-RELATED CANCER,2020 Feb,():,SCI
65 劉淑萱(Liu, Shu-Hsuan)、沈培鈞、(Chen-Yang Chen)、許安霓、卓奕君、賴宥良(Yo-Liang Lai)、(Fang-Hsin Chen)、(Chia-Yang Li)、(Shu-Chi Wang)、(Ming Chen)、(I-Fang Chung)、鄭維中(Cheng, Wei-Chung)*,DriverDBv3: a multi-omics database for cancer driver gene research,NUCLEIC ACIDS RESEARCH,2020 Jan,48(D1):D863-D870,SCI
66 劉良智(Liang-Chih Liu)、王元良(Yuan-Liang Wang)、(Pei-Le Lin)、(Xiang Zhang)、鄭維中(Cheng, Wei-Chung)、(Shu-Hsuan Liu)、陳芝蓉(Chih-Jung Chen)、(Yu Hung)、詹佳穎(Chia-Ing Jan)、張玲菊(Ling-Chu Chang)、(Xiaoyang Qi)、(Linda C. Hsieh-Wilson)、王紹椿(Shao-Chun Wang)*,Long non-coding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15,INTERNATIONAL JOURNAL OF CANCER,2019 Nov,145(9):2478-2487,SCI
67 鄭維中(Cheng, Wei-Chung)、(Tsai-Tsen Liao)、(Chun-Chi Lin)、(Lan-Ting Emily Yuan)、(Hsin-Yi Lan)、(Hung-Hsin Lin)、(Hao-Wei Teng)、(Hsin-Chuan Chang)、(Chi-Hung Lin)、(Chih-Yung Yang)、(Shih-Ching Huang)、(Jeng-Kai Jiang)、(Shung-Haur Yang)、(Muh-Hwa Yang)*、(Wei-Lun Hwang)*,RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer,INTERNATIONAL JOURNAL OF CANCER,2019 Oct,145(8):2209-2224,SCI
68 (Chia?Cheng?Yu)、(Lih?Chyang?Chen)、(Victor C.?Lin)、(Chao?Yuan?Huang)、鄭維中(Cheng, Wei-Chung)、謝璦如、張大元、陸德齡、(Cheng?Hsueh?Lee)、(Shu?Pin?Huang)*、鮑柏穎*,Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy,Cancer Medicine,2019 Jun,8(6):2777-2783,SCI
69 (Chia-Cheng Su)、(Kun-Lin Hsie)、(Po-Len Liu)、(Hsin-Chih Yeh)、(Shu-Pin Huang)、(Shih-Hua Fang)、鄭維中(Cheng, Wei-Chung)、(Kuan-Hua Huang)、(Fang-Yen Chiu)、(I-Ling Lin)、(Ming-Yii Huang)*、(Chia-Yang Li)*,AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2019 Apr,20(7):E1647,SCI
70 高詩涵(Shih-Han Kao)、鄭維中(Cheng, Wei-Chung)、(Yi-Ting Wang)、(Han-Tsang Wu)、葉涵瑜(Ye, Han-Yu)、(Yu-Ju Chen)、蔡銘修(Ming-Hsui Tsai)、吳國瑞(Kou-Juey Wu)*,Regulation of miRNA biogenesis and histone modification by K63-polyubiquitinated DDX17 controls cancer stem-like features,CANCER RESEARCH,2019 Mar,():,SCI
71 (Rai-Hseng Hsu)、(Wuh-Liang Hwu)、(Ming Chen)、(I-Fang Chung)、(Steven Shinn-Forng Peng)、(Chen-Yang Chen)、鄭維中(Cheng, Wei-Chung)、(Yin-Hsiu Chien)、(Ni-Chung Lee)*,Next-generation sequencing identifies TRPV4-related skeletal dysplasia in a boy with progressive bowlegs,Pediatrics and Neonatology,2019 Feb,60(1):102-104,SCI
72 (Yi Han)、(Juze Yang)、(Xinyi Qian)、鄭維中(Cheng, Wei-Chung)、劉淑萱(Liu, Shu-Hsuan)、(Xing Hua)、(Liyuan Zhou)、(Yaning Yang)、(Qingbiao Wu)、(Pengyuan Liu)*、(Yan Lu)*,DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies,NUCLEIC ACIDS RESEARCH,2019 Feb,():,SCI
73 (Wei-Lun Hwang)、(Hsin-Yi Lan)、鄭維中(Cheng, Wei-Chung)*、(Shih-Ching Huang)、(Muh-Hwa Yang),Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer,Journal of Hematology & Oncology,2019 Jan,12(1):10,SCI
74 (Chao?Yuan Huang)、(Yu?Mei Hsueh)、(Lih?Chyang Chen)、鄭維中(Cheng, Wei-Chung)、(Chia?Cheng Yu)、(Wei?Jen Chen)、陸德齡、藍國晉(Lan, Kuo-Jin)、(Cheng?Hsueh Lee)、(Shu?Pin Huang)*、鮑柏穎*,Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival,Cancer Medicine,2018 Dec,7(12):6104-6111,SCI
75 張維君(Chang, Wei-Chun)、鄭維中(Cheng, Wei-Chung)、(Bi-Hua Cheng)、陳璐敏(Lu-Min Chen)、(Li-Jing Ju)、(Yu-Jer Ou)、鄭隆賓(Jeng, Long-Bin)、楊美都(Yang, Mei-Due)、洪耀欽(Hung, Yao-Ching)*、馬文隆(Ma, Wen-Lung)*,Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression,Cancer Medicine,2018 Aug,7(8):3743-3754,SCI
76 (Ming-Yii Huang)、(Chia-En Tu)、(Shu-Chi Wang)、(Yung-Li Hung)、(Chia-Cheng Su)、(Shih-Hua Fang)、(Chi-Shuo Chen)、(Po-Len Liu)、鄭維中(Cheng, Wei-Chung)、(Yu-Wei Huang)、(Chia-Yang Li)*,Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia,BMC Complementary and Alternative Medicine,2018 Aug,18():221,SCI
77 (J.-C. Shih)、(G.-C. Ma)、鄭維中(Cheng, Wei-Chung)、(C.-Y. Chen)、(W.-J. Wu)、(M. Chen)*,SMAD2 as a risk locus for human left atrial isomerism detected by mother-fetus-pair exome sequencing and image studies,Ultrasound in obstetrics & gynecology,2018 May,53():701-708,Other
78 (Ta-Lun Kao)、(Yu-Ping Kuan)、鄭維中(Cheng, Wei-Chung)、張維君(Chang, Wei-Chun)、鄭隆賓(Jeng, Long-Bin)、(Shuyuan Yeh)*、馬文隆(Ma, Wen-Lung)*,Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration,Theranostics,2018 Apr,8(10):2672-2682,SCI
79 (Liang Gong)、(Chee-Hong Wong)、鄭維中(Cheng, Wei-Chung)、(Harianto Tjong)、(Francesca Menghi)、(Chew Yee Ngan)、(Edison T. Liu)、(Chia-Lin Wei)*,Picky comprehensively detects high-resolution structural variants in nanopore long reads,NATURE METHODS,2018 Apr,15(6):455-460,SCI
80 (Kuo-Hua Lin)、(Ming-Yii Huang)、鄭維中(Cheng, Wei-Chung)、(Shu-Chi Wang)、(Shih-Hua Fang)、(Hung-Pin Tu)、(Chia-Cheng Su)、(Yung-Li Hung)、(Po-Len Liu)、(Chi-Shuo Chen)、(Yu-Ting Wang)、(Chia-Yang Li)*,RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment,Scientific Reports,2018 Feb,8():2672,SCI
81 陳璐敏(Lu-Min Chen)、鮑柏穎(Bo-Ying Bao)、張維君(Wei-Chun Chang)、何彥秉、鄭碧華、王中林、(Qifeng Tang)、鄭維中(Wei-Chung Cheng)、張慧雯(Hui-Wen Chang)、洪耀欽(Yao-Ching Hung)*、馬文隆(Wen-Lung Ma)*,Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation,JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2018 Jan,():,SCI
82 范紀鎮(Chi-Chen Fan)、鄭維中(Cheng, Wei-Chung)、黃毓銓(Huang, Yu-Chuen)、佘玉萍(Sher, Yuh-Pyng)、劉乃甄(Nia-Jhen Liou)、簡毓娟(Yu-Chuan Chien)、林佩姍、林佩璇(Pei-Syuan Lin)、陳仲瑄(Chung-Hsuan Chen)、張為超(Chang, Wei-Chao)*,EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma,Scientific Reports,2017 Nov,7(1):14617,SCI
83 吳明儒(Min-Zu Wu)、鄭維中(Cheng, Wei-Chung)、陳素鳳(Chen, Su Feng)、(Shin Nieh)、(Carolyn O'Connor)、(Chia-Lin Liu)、(Wen-Wei Tsai)、(Cheng-Jang Wu)、(Lorena Martin)、(Yaoh-Shiang Lin)、吳國瑞(Wu, Kou-Juey)、(Li-Fan Lu)、(Juan Carlos Izpisua Belmonte)*,miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS,NATURE CELL BIOLOGY,2017 Oct,19(10):1286-1296,SCI
84 (Chiu KL)、林昱森(Yu-Sen Lin)、(Kuo TT)、(Lo CC)、(Huang YK)、(Chang HF)、(Chung EY)、林精湛(Ching-Chan Lin)、鄭維中(Wei-Chung Cheng)、(Liu YN)、(Lai LC)*、佘玉萍(Yuh-Pyng Sher)*,ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis,Oncotarget,2017 May,17648():,SCI
85 (Yung-Li Hung)、(Shih-Hua Fang)、(Shu-Chi Wang)、鄭維中(Wei-Chung Cheng)、(Po-Len Liu)、(Chia-Cheng Su)、(Chi-Shuo Chen)、(Ming-Yii Huang)、(Kuo-Feng Hua)、(Kun-Hung Shen)、(Yu-Ting Wang)、(Katsuhiko Suzuki)、李佳陽*,Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response.,Scientific Reports,2017 Apr,7():46299,SCI
86 張維君(Wei-Chun Chang)、(Shang-Fen Huang)、(Yang-Ming Lee)、賴學洲(Hsueh-Chou Lai)、(Bi-Hua Cheng)、鄭維中(Wei-Chung Cheng)、何彥秉、鄭隆賓(Long-Bin Jeng)、馬文隆(Wen-Lung Ma)*,Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival,Oncotarget,2017 Jan,8(1):692-704,SCI
87 (I-Fang Chung)、(Shing-Jyh Chang)、(Chen-Yang Chen)、劉淑萱(Liu, Shu-Hsuan)、(Chia-Yang Li)、(Chia-Hao Chan)、(Chuan-Chi Shih)、鄭維中(Wei-Chung Cheng)*,YM500v3: a database for small RNA sequencing in human cancer research,NUCLEIC ACIDS RESEARCH,2017 Jan,45(D1):D925-D931,SCI
88 吳函蒼、郭俋志(Yi-Chih Kuo)、洪榮志(Jung-Jyh Hung)、黃濟鴻(Chi-Hung Huang)、陳威儀(Wei-Yi Chen)、周德盈(Teh-Ying Chou)、陳曄(Yeh Chen)、陳誼如(Yi-Ju Chen)、陳玉如(Yu-Ju Chen)、鄭維中(Wei-Chung Cheng)、鄧述諄(Shu-Chun Teng)、吳國瑞(Kou-Juey Wu)*,K63-polyubiquitinated HAUSP deubiquitinates HIF-1 alpha and dictates H3K56 acetylation promoting hypoxia-induced tumor progression,Nature Communications,2016 Dec,7(*):1-17,SCI
89 賴學洲(Hsueh-Chou Lai)、葉俊杰(Chun-Chieh Yeh)、鄭隆賓(Long-Bin Jeng)、黃上峰(Shang-Fen Huang)、廖珮吟(Liao, Pei-Yin)、雷馥如(Lei, Fu Ju)、鄭維中(Wei-Chung Cheng)、徐正龍(Cheng-Lung Hsu)、蔡秀軍(Xiujun Cai)、張傳祥(Chawnshang Chang)、馬文隆(Wen-Lung Ma)*,Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells,Oncotarget,2016 Jul,():,SCI
90 (I-Fang Chung)、(Chen-Yang Chen)、(Shih-Chieh Su)、(Chia-Yang Li)、吳國瑞(Kou-Juey Wu)、(Hsei-Wei Wang)*、鄭維中*,DriverDBv2: a database for human cancer driver gene research,NUCLEIC ACIDS RESEARCH,2016 Jan,44(D1):D975-D979,SCI
91 蔡雅萍(Ya-Ping Tsai)、陳筱凡(Hsiao-Fan Chen)、陳松遠(Sung-Yuan Chen)、鄭維中、王學偉(Hsei-Wei Wang)、沈子傑(Zih-Jie Shen)、(Chunxiao Song)、鄧述諄(Shu-Chun Teng)、(Chuan He)、吳國瑞(Kou-Juey Wu)*,TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator,GENOME BIOLOGY,2014 Dec,15(00):513-525,SCI
92 鄭維中、鐘翊方(I-Fang Chung)、蔡晨峰(Cheng-Fong Tsai)、黃則舜(Tse-Shun Huang)、陳晨陽(Chen-Yang Chen)、王紹全(Shao-Chuan Wang)、張庭毓(Ting-Yu Chang)、孫行人(Hsing-Jen Sun)、趙勇全(Yung-Chuan Chao)、鄭正忠(Cheng-Chung Cheng)、吳成文(Cheng-Wen Wu)、王學偉(Hsei-Wei Wang)*,YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research.,NUCLEIC ACIDS RESEARCH,2014 Nov,43(D1):D862-D867,SCI